Bang & Olufsen A/S
Bang & Olufsen A/S – share buyback programme to hedge the company’s share-based incentive programmes
Bang & Olufsen A/S – share buyback programme to hedge the company’s share-based incentive programmes
On 15 August 2025, Bang & Olufsen initiated a share buyback programme with the purpose of hedging the company’s share-based long-term incentive programmes in accordance with EU Commission Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the “Safe Harbour Regulation”).
Under the share buyback programme, which runs from 15 August 2025 and will end no later than 14 August 2026, Bang & Olufsen intends to buy back shares for an amount of up to DKK 65 million.
The following transactions have been made under the program in the period 15 to 22 August 2025.
No. of shares | Average purchase price (DKK) | Transaction value (DKK) | |
15 August 2025 | 25,000 | 13.19 | 329,670.00 |
18 August 2025 | 20,000 | 14.13 | 282,672.00 |
19 August 2025 | 25,000 | 14.64 | 366,032.50 |
20 August 2025 | 25,000 | 14.62 | 365,535.00 |
21 August 2025 | 25,000 | 15.03 | 375,652.50 |
22 August 2025 | 30,000 | 15.30 | 458,865.00 |
Total this period | 150,000 | 14.52 | 2,178,427.00 |
Accumulated under the programme | 150,000 | 14.52 | 2,178,427.00 |
Following the above transactions, Bang & Olufsen holds a total of 3,263,183 own shares corresponding to 2.21% of the total share capital and the total voting rights in the company.
Details of each transaction are included as appendix.
For further information, please contact: Sr. Director, Strategy & Investor Relations, Cristina Rønde Hefting, phone: +45 4153 7303.
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Oil-Dri Corporation Of America25.8.2025 22:00:00 CEST | Press release
Amlan® to Present on Biotoxin Control and Antibiotic-Free Poultry Production at Malaysia Livestock 2025
King Faisal Specialist Hospital & Research Centre25.8.2025 21:16:42 CEST | Press release
Over 2,000 Successful Surgeries for Drug-Resistant Epilepsy
F. Hoffmann-La Roche Ltd25.8.2025 20:30:00 CEST | Press release
Roche’s US subsidiary Genentech breaks ground on state-of-the-art manufacturing facility in North Carolina, USA
Recor Medical25.8.2025 18:21:49 CEST | Press release
Recor Medical Announces Paradise Ultrasound Renal Denervation System Receives Manufacturing and Marketing Approval in Japan for the Treatment of Resistant Hypertension
Vaisala Group25.8.2025 17:30:00 CEST | Press release
Vaisala Corporation: Share Repurchase 25.8.2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom